Dimethyl-diphenyl-propanamide derivatives as nonsteroidal dissociated glucocorticoid receptor agonists

  • Bingwei V. Yang
  • , David S. Weinstein
  • , Lidia M. Doweyko
  • , Hua Gong
  • , Wayne Vaccaro
  • , Tram Huynh
  • , Hai Yun Xiao
  • , Arthur M. Doweyko
  • , Lorraine McKay
  • , Deborah A. Holloway
  • , John E. Somerville
  • , Sium Habte
  • , Mark Cunningham
  • , Michele McMahon
  • , Robert Townsend
  • , David Shuster
  • , John H. Dodd
  • , Steven G. Nadler
  • , Joel C. Barrish

Research output: Contribution to journalArticlepeer-review

36 Scopus citations

Abstract

A series of 2,2-dimethyl-3,3-diphenyl-propanamides as novel glucocorticoid receptor modulators is reported. SAR exploration led to the identification of 4-hydroxyphenyl propanamide derivatives displaying good agonist activity in GR-mediated transrepression assays and reduced agonist activity in GR-mediated transactivation assays. Compounds 17 and 30 showed anti-inflammatory activity comparable to prednisolone in the rat carrageenan-induced paw edema model, with markedly decreased side effects with regard to increases in blood glucose and expression of hepatic tyrosine aminotransferase. A hypothetical binding mode accounting for the induction of the functional activity by a 4-hydroxyl group is proposed.

Original languageEnglish (US)
Pages (from-to)8241-8251
Number of pages11
JournalJournal of Medicinal Chemistry
Volume53
Issue number23
DOIs
StatePublished - Dec 9 2010

All Science Journal Classification (ASJC) codes

  • Molecular Medicine
  • Drug Discovery

Fingerprint

Dive into the research topics of 'Dimethyl-diphenyl-propanamide derivatives as nonsteroidal dissociated glucocorticoid receptor agonists'. Together they form a unique fingerprint.

Cite this